Terapi SIRT Dokter Terbaik di Israel - TOP-9 dokter

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – salah satu departemen onkologi terkemuka di Israel.

• Lebih dari 25 tahun spesialisasi dalam sarkoma dan tumor tulang
• Menjalani pelatihan *Fellowship* di Institut Gustave Roussy di Paris
• Anggota Fakultas Sarkoma ESMO dan ASCO
• Telah memublikasikan secara luas mengenai perawatan onkologi ortopedi

Dr. Pelles Sharon berspesialisasi dalam terapi SIRT di Sourasky Medical Center, membawa keahlian luas dalam perawatan kanker tingkat lanjut.

• Onkolog yang sangat dihormati dengan kontribusi signifikan pada penelitian klinis
• Melakukan berbagai macam operasi dan terapi kanker
• Ahli dalam Kemoterapi Intraperitoneal Hipertermik (HIPEC)
• Terampil dalam imunoterapi dan pendekatan terapi target

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Greenberg memimpin Departemen Bedah Kolorektal di Pusat Medis Sourasky dengan pengalaman bedah lebih dari 20 tahun.

• Berspesialisasi dalam teknik terbuka dan invasif minimal
• Ahli dalam prosedur bedah Whipple
• Bekerja di salah satu pusat medis terkemuka di Israel

Direktur rawat inap onkologi di Pusat Medis Tel Aviv – Dr. Stepfansky berspesialisasi dalam terapi SIRT dengan pengalaman penelitian klinis yang luas.

• Lebih dari 15 tahun praktik onkologi
• Peneliti utama dalam berbagai uji klinis
• Pelatihan di Pusat Medis Tel Aviv
• Berspesialisasi dalam penyakit dalam dan onkologi

Pengalaman 28+ tahun berspesialisasi dalam kanker hati dan pankreas – Dr. Ben-haim adalah pakar terkemuka dalam onkologi gastrointestinal kompleks di Sourasky Medical Center.

• Melakukan operasi Whipple dan intervensi lanjutan lainnya
• Fokus secara eksklusif pada kasus onkologi gastrointestinal
• Diakui sebagai salah satu spesialis kanker hati terbaik di Israel

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.